Resolve Biosciences raises USD 71m in Series B financing

Resolve BioSciences GmbH, the Germany and US based molecular cartography technology company, has raised USD 71m in a Series B funding round led by Patient Square Capital LLP, the US based private equity firm, with participation from PS Capital Management, the Germany based family office, EDBI, the Singapore based global investment company, Alafi Capital, the US based venture capital firm, NRW.BANK, the Germany based development bank, and other undisclosed existing investors.

Target – Resolve BioSciences GmbH

Buyer – PS Capital Management GmbH

Buyer – Patient Square Capital LLP

Buyer – EDBI Pte Ltd

Buyer – Alafi Capital

Buyer – NRW.BANK

Buyer – Undisclosed Existing Investors

Seller – Shareholders

Bridgepoint Advisers has agreed to acquire Alpha FMC

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Bridgepoint Advisers to make an offer for Alpha Financial

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Wakeo acquires Veroo Software

Wakeo, the France based provider of a SaaS platform providing real-time visibility on international transport flows (sea, air, road) to …

Read More →

Bregal Unternehmerkapital to acquire a majority stake in Relatech S.p.A.

Bregal Unternehmerkapital GmbH, the Germany based private equity firm, through Gemini BidCo, a special purpose vehicle indirectly controlled by the …

Read More →

DeepForm raises GBP 2m

DeepForm Limited, the UK based company, that specializes in developing and offering novel press tool designs, which help reduce material …

Read More →

PINOVA Capital invests in NEUROMEDEX

Neuromedex, the Germany based provider of disposable products for neurosurgery and intensive care, has been acquired by Pinova Capital GmbH, …

Read More →
close-link
close-link